GE sells BioPharma unit for $21.4bn, cuts debt as it prepares for virus slowdown


The risk to General Electric’s (NYSE: GE) completed the sale of its BioPharma business for $21.4bn to US conglomerate Danaher, reducing its debt.

The sale on Tuesday will bring $2obn in cash in a critical time when its entire business model is exposed to a downturn, due to the slowdown in economic activity caused by the coronavirus pandemic.

The sale of the BioPharma business is in line with the chief executive Larry Culp’s strategy of trimming its business model by selling non-core assets and using the proceeds for cutting the group’s debt along with investing in power and industrial businesses. The company had sold $12bn of assets last year and reduced its net debt by $7bn.

GE stock was down just under 8% at $7.33 in afternoon trading on Wednesday, and is down 38.6% this year. The S&P 500 is down 20% in 2020.

“Completing the sale of BioPharma represents a critical milestone on our multi-year transformation, fortifying our considerable sources to de-risk our balance sheet and continue to solidify our financial position. I am proud of the teams for completing this transaction amidst a great deal of global change,” said GE’s Culp.

GE sells BioPharma unit...

Previously, Culp said that GE’s all businesses including aviation will see significant consequences of coronavirus impact on the global economy and consumer sentiments. GE announced to cut its 10% of the aviation workforce; the company expects to save between $500m and $1bn this year in the wake of slowing demand.

Market analysts are showing concerns over GE’s potential to achieve internal cash flow generation targets following the demand slump and challenges for its aviation business which accounts for 75% of its total profit.

“The up portion of GE Aviation free cash flow assumption for 2020 now seems aggressive, given the fleet groundings and requests by airlines for financial support,” Gordon Haskett analyst John Inch says. However, the analyst anticipates that the company is unlikely to face liquidity issues considering its $35bn bank syndicate facility. GE stock price is currently trading under $8 while Credit Suisse sets price target at $13 and Cowen provides $11 price target.

Open a Stocks Account and Get $5 Free

  • Platform
  • Features
  • Rating
  • Visit Site
  • Sign up now and claim a $5 reward
  • Low minimum investment starting at $5
  • No minimum deposit to open an account
  • Fractional shares are available



    https://learnbonds.com/visit/StashCreate your account
    Hide Reviews
    All trading carries risk. Views expressed are those of the writers only. Past performance is no guarantee of future results. The opinions expressed in this Site do not constitute investment advice and independent financial advice should be sought where appropriate. This website is free for you to use but we may receive commission from the companies we feature on this site.

    Based in Saudi Arabia, Siraj has a strong understanding of and passion for accounting and finance. He has worked for international clients for many years on several projects related to the stock market, equity research and other business, accounting and finance related projects. Siraj is a published financial analyst on the world's leading websites including SeekingAlpha, TheStreet, MSN, and others.


    Leading Social Trading Platform with 0% Commission

    Leading Social Trading Platform with 0% Commission

    Leading Social Trading Platform with 0% Commission


    75% of investors lose money when trading CFDs.

    Leading Social Trading Platform with 0% Commission

    75% of investors lose money when trading CFDs.

    HTML Snippets Powered By : XYZScripts.com